ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

Adriamycin Fact Sheet Available

July 4, 1975

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

April 25, 2014

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997